Shared genetic risk between migraine and coronary artery disease: A genome-wide analysis of common variants

Research output: Contribution to journalJournal articleResearchpeer-review

Documents

  • Fulltext

    Final published version, 2.89 MB, PDF document

  • Bendik S. Winsvold
  • Francesco Bettella
  • Aree Witoelar
  • Verneri Anttila
  • Padhraig Gormley
  • Tobias Kurth
  • Gisela M. Terwindt
  • Tobias Freilinger
  • Oleksander Frei
  • Alexey Shadrin
  • Yunpeng Wang
  • Anders M. Dale
  • Arn M.J.M. van den Maagdenberg
  • Dale R. Nyholt
  • Aarno Palotie
  • Ole A. Andreassen
  • John Anker Zwart
  • Ville Artto
  • Andrea Carmine Belin
  • Dorret I. Boomsma
  • Sigrid Børte
  • Daniel I. Chasman
  • Lynn Cherkas
  • Anne Francke Christensen
  • Bru Cormand
  • Ester Cuenca-Leon
  • George Davey-Smith
  • Martin Dichgans
  • Cornelia van Duijn
  • Else Eising
  • Tonu Esko
  • Ann Louise Esserlind
  • Michel Ferrari
  • Rune R. Frants
  • Tobias Freilinger
  • Nick Furlotte
  • Lyn Griffiths
  • Eija Hamalainen
  • Hansen, Thomas Folkmann
  • Marjo Hiekkala
  • M. Arfan Ikram
  • Andres Ingason
  • Marjo Riitta Järvelin
  • Risto Kajanne
  • Mikko Kallela
  • Jaakko Kaprio
  • Mari Kaunisto
  • Christian Kubisch
  • Mitja Kurki
  • Olesen, Jes
  • International Headache Genetics Consortium

Migraine is a recurrent pain condition traditionally viewed as a neurovascular disorder, but little is known of its vascular basis. In epidemiological studies migraine is associated with an increased risk of cardiovascular disease, including coronary artery disease (CAD), suggesting shared pathogenic mechanisms. This study aimed to determine the genetic overlap between migraine and CAD, and to identify shared genetic risk loci, utilizing a conditional false discovery rate approach and data from two large-scale genome-wide association studies (GWAS) of CAD (C4D, 15,420 cases, 15,062 controls; CARDIoGRAM, 22,233 cases, 64,762 controls) and one of migraine (22,120 cases, 91,284 controls). We found significant enrichment of genetic variants associated with CAD as a function of their association with migraine, which was replicated across two independent CAD GWAS studies. One shared risk locus in the PHACTR1 gene (conjunctional false discovery rate for index SNP rs9349379 < 3.90 x 10−5), which was also identified in previous studies, explained much of the enrichment. Two further loci (in KCNK5 and AS3MT) showed evidence for shared risk (conjunctional false discovery rate < 0.05). The index SNPs at two of the three loci had opposite effect directions in migraine and CAD. Our results confirm previous reports that migraine and CAD share genetic risk loci in excess of what would be expected by chance, and highlight one shared risk locus in PHACTR1. Understanding the biological mechanisms underpinning this shared risk is likely to improve our understanding of both disorders.

Original languageEnglish
Article numbere0185663
JournalPLoS ONE
Volume12
Issue number9
Number of pages15
ISSN1932-6203
DOIs
Publication statusPublished - 2017

Bibliographical note

Publisher Copyright:
© 2017 Winsvold et al. This is an open access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.

ID: 309204389